Suda Pharmaceuticals Liabilities 2024

Suda Pharmaceuticals Aktienanalyse

What does Suda Pharmaceuticals do?

Suda Pharmaceuticals Ltd is an Australian pharmaceutical company specializing in the development and marketing of drugs. The company was founded in 2000 and is headquartered in Perth, Western Australia. It is listed on the Australian Stock Exchange and has offices in the UK and the USA. Suda Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Suda Pharmaceuticals's Liabilities

Suda Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Suda Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Suda Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Suda Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Suda Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Suda Pharmaceuticals stock

What is the level of liabilities of Suda Pharmaceuticals this year?

Suda Pharmaceuticals has a debt balance of 1.71 M AUD this year.

What were the liabilities of Suda Pharmaceuticals compared to the previous year?

The liabilities of Suda Pharmaceuticals have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Suda Pharmaceuticals?

High liabilities can pose a risk for investors of Suda Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Suda Pharmaceuticals?

Low liabilities mean that Suda Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Suda Pharmaceuticals affect the company?

An increase in liabilities of Suda Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Suda Pharmaceuticals affect the company?

A decrease in the liabilities of Suda Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Suda Pharmaceuticals?

Some factors that can influence the liabilities of Suda Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Suda Pharmaceuticals so important for investors?

The liabilities of Suda Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Suda Pharmaceuticals take to modify the liabilities?

To change its liabilities, Suda Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Suda Pharmaceuticals pay?

Over the past 12 months, Suda Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Suda Pharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Suda Pharmaceuticals?

The current dividend yield of Suda Pharmaceuticals is .

When does Suda Pharmaceuticals pay dividends?

Suda Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Suda Pharmaceuticals?

Suda Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Suda Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Suda Pharmaceuticals located?

Suda Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Suda Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Suda Pharmaceuticals from 9/7/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/7/2024.

When did Suda Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/7/2024.

What was the dividend of Suda Pharmaceuticals in the year 2023?

In the year 2023, Suda Pharmaceuticals distributed 0 AUD as dividends.

In which currency does Suda Pharmaceuticals pay out the dividend?

The dividends of Suda Pharmaceuticals are distributed in AUD.